Rep. Thomas H. Kean, Jr. Sells Stryker Corporation (NYSE:SYK) Stock

Key Points

• Representative Thomas H. Kean, Jr. sold shares of Stryker Corporation (NYSE:SYK) worth between $15,001 and $50,000 on July 31st, as disclosed in a filing.
• Stryker's stock has recently declined by 1.8%, with a 52-week range of $329.16 to $406.19, and a market capitalization of $147.06 billion.
• The company announced a quarterly dividend of $0.84 per share, with an ex-dividend date of September 30th, reflecting a yield of 0.9%.

Representative Thomas H. Kean, Jr. (R-New Jersey) recently sold shares of Stryker Corporation NYSE: SYK. In a filing disclosed on August 20th, the Representative disclosed that they had sold between $15,001 and $50,000 in Stryker stock on July 31st.

Representative Thomas H. Kean, Jr. also recently made the following trade(s):

• Sold $15,001 - $50,000 in shares of Johnson & Johnson NYSE: JNJ on 7/31/2025.
• Purchased $15,001 - $50,000 in shares of Check Point Software Technologies NASDAQ: CHKP on 7/29/2025.
• Sold $1,001 - $15,000 in shares of Adobe NASDAQ: ADBE on 7/29/2025.
• Purchased $1,001 - $15,000 in shares of Abbott Laboratories NYSE: ABT on 7/21/2025.
• Purchased $1,001 - $15,000 in shares of Prologis NYSE: PLD on 6/30/2025.
• Sold $15,001 - $50,000 in shares of Stryker NYSE: SYK on 6/26/2025.
• Sold $1,001 - $15,000 in shares of WESCO International NYSE: WCC on 6/23/2025.
• Purchased $1,001 - $15,000 in shares of Danaher NYSE: DHR on 6/11/2025.
• Purchased $1,001 - $15,000 in shares of AON NYSE: AON on 5/27/2025.

Stryker Stock Down 1.8%

Shares of SYK opened at $384.6550 on Friday. Stryker Corporation has a 52-week low of $329.16 and a 52-week high of $406.19. The company has a quick ratio of 1.06, a current ratio of 1.78 and a debt-to-equity ratio of 0.70. The stock has a fifty day simple moving average of $387.17 and a two-hundred day simple moving average of $379.49. The company has a market capitalization of $147.06 billion, a PE ratio of 50.95, a price-to-earnings-growth ratio of 2.85 and a beta of 0.91.

Stryker (NYSE:SYK - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The medical technology company reported $3.13 earnings per share for the quarter, beating the consensus estimate of $3.07 by $0.06. Stryker had a net margin of 12.25% and a return on equity of 23.94%. The firm had revenue of $6.02 billion for the quarter, compared to analysts' expectations of $5.92 billion. During the same quarter in the previous year, the company posted $2.81 EPS. The company's revenue was up 11.1% compared to the same quarter last year. Stryker has set its FY 2025 guidance at 13.400-13.600 EPS. As a group, equities analysts forecast that Stryker Corporation will post 13.47 EPS for the current year.

Stryker Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Tuesday, September 30th will be issued a $0.84 dividend. This represents a $3.36 annualized dividend and a yield of 0.9%. The ex-dividend date is Tuesday, September 30th. Stryker's dividend payout ratio is presently 44.50%.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of the company. Mid American Wealth Advisory Group Inc. acquired a new position in shares of Stryker in the second quarter worth $26,000. Capital A Wealth Management LLC purchased a new position in Stryker in the fourth quarter valued at $26,000. Elevation Point Wealth Partners LLC acquired a new position in Stryker during the 2nd quarter worth $28,000. Sachetta LLC grew its stake in Stryker by 58.7% during the 2nd quarter. Sachetta LLC now owns 73 shares of the medical technology company's stock worth $29,000 after purchasing an additional 27 shares in the last quarter. Finally, Kilter Group LLC purchased a new stake in Stryker during the 2nd quarter worth about $29,000. 77.09% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

SYK has been the topic of several recent analyst reports. Wells Fargo & Company boosted their target price on shares of Stryker from $435.00 to $445.00 and gave the company an "overweight" rating in a report on Friday, August 1st. Wall Street Zen raised shares of Stryker from a "hold" rating to a "buy" rating in a research report on Friday, July 18th. Citigroup reiterated a "buy" rating and issued a $455.00 price objective (up from $443.00) on shares of Stryker in a report on Thursday, May 22nd. BTIG Research reissued a "buy" rating on shares of Stryker in a research note on Monday, July 14th. Finally, Sanford C. Bernstein set a $450.00 target price on Stryker in a research report on Monday, May 5th. Fifteen research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $430.10.

Insider Transactions at Stryker

In other news, Director Ronda E. Stryker sold 200,000 shares of Stryker stock in a transaction dated Wednesday, August 6th. The stock was sold at an average price of $376.45, for a total value of $75,290,000.00. Following the completion of the transaction, the director owned 3,222,108 shares in the company, valued at approximately $1,212,962,556.60. This trade represents a 5.84% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 5.90% of the stock is owned by corporate insiders.

About Representative Kean

Thomas Kean Jr. (Republican Party) is a member of the U.S. House, representing New Jersey's 7th Congressional District. He assumed office on January 3, 2023. His current term ends on January 3, 2027. Kean (Republican Party) is running for re-election to the U.S. House to represent New Jersey's 7th Congressional District. He declared candidacy for the 2026 election. Thomas Kean Jr. lives in Westfield, New Jersey. Kean earned a master’s degree from the Tufts University Fletcher School of Law and Diplomacy. His career experience includes working with the Environmental Protection Agency during the George H.W. Bush administration and as an advisor to former U.S. Representative Bob Franks, a firefighter, and an emergency medical technician. Kean has served as the vice president of a fire department.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.